Stockreport

BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3 [Yahoo! Finance]

BriaCell Therapeutics Corp. - Common Shares  (BCTX) 
PDF Highly expressed on the cell surfaces of both tumor and immune cells, B7-H3 is a promising anti-cancer target for drugs both effecting cancer cells and blocking immune [Read more]